NCT00350753View on ClinicalTrials.gov

Avastin and Tarceva for Upper Gastrointestinal Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
CholangiocarcinomaGallbladder Cancer
Interventions
DRUG

Erlotinib and bevacizumab

Erlotonib 150 mg daily bevacizumab 10 mg/kg every 14 days

Trial Locations (3)

2100

Rigshospitalet, Copenhagen

5000

Odense University Hospital, Odense

8000 C

Århus Sygehus, Aarhus

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT00350753 - Avastin and Tarceva for Upper Gastrointestinal Cancers | Biotech Hunter | Biotech Hunter